Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad: Our Bureau, ...

Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...

Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden: Ter Apel, Netherlands Wednesday, July 30, 2025, 13:00 Hrs [IST] ...

EMA committee recommends approval of BeOne Medicines’ Tevimbra to treat neoadjuvant/adjuvant NSCLC: San Carlos, California Wednesday, July 30, 2025, 12:00 Hrs [IST] BeOne Medici ...

Strides posts in Q1 FY26 revenues of Rs. 1,119.7 crore, clocks Rs. 11.4.crore in operational PAT: Our Bureau, Bengaluru Wednesday, July 30, 2025, 10:45 Hrs [IST] Strides Pharma Sc ...

Avidity Biosciences completes enrolment in HARBOR phase 3 trial of delpacibart etedesiran to treat myotonic dystrophy type 1: San Diego Wednesday, July 30, 2025, 10:00 Hrs [IST] A ...

Waltham, Massachusetts Wednesday, July 30, 2025, 11:00 Hrs [IST] ...

Peethaambaran Kunnathoor, Chennai Wednesday, July 30, 2025, 08:00 Hrs [IST] ...

Govt. Schemes helped growth of medical devices exports to 88% in six years: Centre: Gireesh Babu, New Delhi Wednesday, July 30, 2025, 08:00 Hrs [IST] The Schemes supporting develo ...

A culture of quality excipients has ushered in as the pharmaceutical industry advances towards manufacturing super and complex generics which requires high precision levels of process controls, Good ...

DGTR initiates anti-dumping probe on imports of “Bromo OTBN” from China: Shardul Nautiyal, Mumbai Wednesday, July 30, 2025, 08:00 Hrs [IST] Aimed at safeguarding domestic indu ...

Indian nutraceutical companies grapple with a maze of global regulatory challenges: Nandita Vijayasimha, Bengaluru Wednesday, July 30, 2025, 08:00 Hrs [IST] Indian nutraceutical c ...